Ability Pharmaceuticals
Business Services · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Cerdanyola 08290, Barcelona, Catalonia, ...Phone Number
+34 935824411Website
www.abilitypharma.comRevenue
$8.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ability Pharmaceuticals
Ability Pharmaceuticals (www.abilitypharma.com) is a clinical-stage biopharmaceutical company focused on creating the future of oncology by developing innovative therapies that address unmet medical needs. Established in 2009 and with two drug candidates in development: ABTL0812, a targeted therapy already in phase 2 clinical trials and ABTL0815 in preclinical development, AbilityPharma is positioning itself as one of the fast growers in the Catalan and Spanish biotech sector. In April 2016, AbilityPharma signed a territorial license agreement for ABTL0812 with the NASDAQ US company SciClone Pharmaceuticals, Inc. to develop and market the product in Greater China. Ability Pharmaceuticals has headquarters in Cerdanyola del Vallès (Barcelona, Catalonia, Spain) at Parc Tecnològic del Vallès and Parc de Recerca UAB. Current shareholders include the biotech venture firms Inveready and SODENA, its founders and private investors, and has the financial support from ACCIO (Government of CatalonRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ability Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ability Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Ability Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Ability Pharmaceuticals launches new products
Check if Ability Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Ability Pharmaceuticals has new funding data
Earning: See what the market has to say on Ability Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Ability Pharmaceuticals
Click to see if Ability Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Ability Pharmaceuticals as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Ability Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ability Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ability Pharmaceuticals.
Ability Pharmaceuticals financials insights
Gather financial insights about Ability Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$7.6M
Ability Pharmaceuticals Tech Stack
A closer look at the technologies used by Ability Pharmaceuticals
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Events
Funding
Funding
Event
Ability Pharmaceuticals News & Media
AbilityPharma Announces FDA Approval of IND for Phase 2 Trial of ABTL0812 in Patients with Endometrial Cancer or Squamous Non-Small Cell Lung Cancer
BARCELONA, Spain, December 13, 2017 /PRNewswire/ -- Ability Pharmaceuticals SL, a biopharmaceutical company, announced today that the United States Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application which allows AbilityPharma to proceed with...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ability Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Ability Pharmaceuticals (www.abilitypharma.com) is a clinical-stage biopharmaceutical company focused on creating the future of oncology by developing innovative therapies that address unmet medical needs. Established in 2009 and with two drug candidates in development: ABTL0812, a targeted therapy already in phase 2 clinical trials and ABTL0815 in... Read More
